Skip to content

Supplementation of Angiotensin-(1-7) formulations and their actions on physical performance and repair of muscle damage in recreational athletes and in physically active and sedentary people

Angiotensin formulations-(1-7) its actions on physical performance and injury repair muscular

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3bhkdg2
Enrollment
Unknown
Registered
2024-06-06
Start date
2024-03-28
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Functional Performance

Interventions

This is a double-blind, randomized crossover study. The sample will be 74 volunteers. Individuals will be distributed into 03 distinct groups: Group 01: Individuals who practice cycling (n= 12 volunte

Sponsors

Universidade Federal de Ouro Preto
Lead Sponsor
Universidade Federal de Minas Gerais - UFMG/ Departamento de Fisiologia e Biofísica
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Healthy individuals who have been cycling and boxing for at least 3 years; sedentary individuals; non-smoking; be over 18 years old; use medications such as anti-inflammatories and antibiotics and/or others that could compromise research data; as well as consuming supplements that interfere with physical performance

Exclusion criteria

Exclusion criteria: Do not sign the TCLE of the volunteer's free will; failure to attend the physical test battery on the scheduled day and time; present some type of illness that compromises data collection; who start using medications such as anti-inflammatories and antibiotics and/or others that could compromise research data; as well as starting to consume supplements that interfere with physical performance

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: Evaluate the therapeutic potential in prior treatment against muscle damage, as well as in improving the physical performance of healthy people and athletes

Secondary

MeasureTime frame
Expected outcome 2: Provide the market with a previously tested safe formulation

Countries

Brazil

Contacts

Public ContactLenice Becker

Universidade Federal de Ouro Preto

lenice@ufop.edu.br+55 (31) 3559-1960

Outcome results

None listed

Source: REBEC (via WHO ICTRP)